| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
688 |
558 |
$982K |
| 67228 |
|
1,449 |
1,071 |
$436K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,284 |
4,182 |
$408K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,230 |
3,399 |
$403K |
| 92134 |
|
10,935 |
10,418 |
$400K |
| 67210 |
|
763 |
685 |
$342K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
119 |
96 |
$177K |
| 92235 |
|
1,242 |
1,241 |
$143K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
826 |
826 |
$137K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,468 |
1,402 |
$122K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,945 |
1,610 |
$121K |
| 92250 |
|
2,513 |
2,355 |
$100K |
| 92273 |
|
751 |
747 |
$74K |
| 92202 |
|
3,304 |
3,241 |
$41K |
| 92226 |
|
1,138 |
786 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
240 |
232 |
$31K |
| 92225 |
|
490 |
352 |
$15K |
| 92201 |
|
651 |
638 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63 |
60 |
$5K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
29 |
29 |
$3K |
| 76512 |
|
66 |
52 |
$3K |
| 99024 |
|
33 |
25 |
$0.00 |